United States Next-Generation Biologics Market Report 2016

Table of Contents

United States Next-Generation Biologics Market Report 2016
1 Next-Generation Biologics Overview
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics
1.2.1 Antibodies
1.2.2 Regenerative medicine
1.2.3 Insulins
1.2.4 Growth hormones
1.2.5 Other
1.3 Application of Next-Generation Biologics
1.3.1 Medical
1.3.2 Scientific Research
1.3.3 Other
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Next-Generation Biologics (2011-2021)
1.4.1 United States Next-Generation Biologics Sales and Growth Rate (2011-2021)
1.4.2 United States Next-Generation Biologics Revenue and Growth Rate (2011-2021)

2 United States Next-Generation Biologics Competition by Manufacturers
2.1 United States Next-Generation Biologics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Next-Generation Biologics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Next-Generation Biologics Average Price by Manufactures (2015 and 2016)
2.4 Next-Generation Biologics Market Competitive Situation and Trends
2.4.1 Next-Generation Biologics Market Concentration Rate
2.4.2 Next-Generation Biologics Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Next-Generation Biologics Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Next-Generation Biologics Sales and Market Share by Type (2011-2016)
3.2 United States Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
3.3 United States Next-Generation Biologics Price by Type (2011-2016)
3.4 United States Next-Generation Biologics Sales Growth Rate by Type (2011-2016)

4 United States Next-Generation Biologics Sales (Volume) by Application (2011-2016)
4.1 United States Next-Generation Biologics Sales and Market Share by Application (2011-2016)
4.2 United States Next-Generation Biologics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Next-Generation Biologics Manufacturers Profiles/Analysis
5.1 Allergan
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Next-Generation Biologics Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer
5.2.2 Next-Generation Biologics Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Biogen Idec
5.3.2 Next-Generation Biologics Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Eli Lilly
5.4.2 Next-Generation Biologics Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Kyowa Hakko Kirin
5.5.2 Next-Generation Biologics Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Molecular Partners
5.6.2 Next-Generation Biologics Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Next-Generation Biologics Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Pfizer
5.8.2 Next-Generation Biologics Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Roche
5.9.2 Next-Generation Biologics Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Sanofi
5.10.2 Next-Generation Biologics Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 Next-Generation Biologics Manufacturing Cost Analysis
6.1 Next-Generation Biologics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Next-Generation Biologics

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Next-Generation Biologics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Next-Generation Biologics Market Forecast (2016-2021)
10.1 United States Next-Generation Biologics Sales, Revenue Forecast (2016-2021)
10.2 United States Next-Generation Biologics Sales Forecast by Type (2016-2021)
10.3 United States Next-Generation Biologics Sales Forecast by Application (2016-2021)
10.4 Next-Generation Biologics Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer


List of Tables and Figures

Figure Picture of Next-Generation Biologics
Table Classification of Next-Generation Biologics
Figure United States Sales Market Share of Next-Generation Biologics by Type in 2015
Figure Antibodies Picture
Figure Regenerative medicine Picture
Figure Insulins Picture
Figure Growth hormones Picture
Figure Other Picture
Table Application of Next-Generation Biologics
Figure United States Sales Market Share of Next-Generation Biologics by Application in 2015
Figure Medical Examples
Figure Scientific Research Examples
Figure Other Examples
Figure United States Next-Generation Biologics Sales and Growth Rate (2011-2021)
Figure United States Next-Generation Biologics Revenue and Growth Rate (2011-2021)
Table United States Next-Generation Biologics Sales of Key Manufacturers (2015 and 2016)
Table United States Next-Generation Biologics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Next-Generation Biologics Sales Share by Manufacturers
Figure 2016 Next-Generation Biologics Sales Share by Manufacturers
Table United States Next-Generation Biologics Revenue by Manufacturers (2015 and 2016)
Table United States Next-Generation Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Next-Generation Biologics Revenue Share by Manufacturers
Table 2016 United States Next-Generation Biologics Revenue Share by Manufacturers
Table United States Market Next-Generation Biologics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Next-Generation Biologics Average Price of Key Manufacturers in 2015
Figure Next-Generation Biologics Market Share of Top 3 Manufacturers
Figure Next-Generation Biologics Market Share of Top 5 Manufacturers
Table United States Next-Generation Biologics Sales by Type (2011-2016)
Table United States Next-Generation Biologics Sales Share by Type (2011-2016)
Figure United States Next-Generation Biologics Sales Market Share by Type in 2015
Table United States Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
Table United States Next-Generation Biologics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Next-Generation Biologics by Type (2011-2016)
Table United States Next-Generation Biologics Price by Type (2011-2016)
Figure United States Next-Generation Biologics Sales Growth Rate by Type (2011-2016)
Table United States Next-Generation Biologics Sales by Application (2011-2016)
Table United States Next-Generation Biologics Sales Market Share by Application (2011-2016)
Figure United States Next-Generation Biologics Sales Market Share by Application in 2015
Table United States Next-Generation Biologics Sales Growth Rate by Application (2011-2016)
Figure United States Next-Generation Biologics Sales Growth Rate by Application (2011-2016)
Table Allergan Basic Information List
Table Allergan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Next-Generation Biologics Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Next-Generation Biologics Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Next-Generation Biologics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Next-Generation Biologics Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Next-Generation Biologics Sales Market Share (2011-2016)
Table Molecular Partners Basic Information List
Table Molecular Partners Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Molecular Partners Next-Generation Biologics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Next-Generation Biologics Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Next-Generation Biologics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Next-Generation Biologics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Next-Generation Biologics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next-Generation Biologics
Figure Manufacturing Process Analysis of Next-Generation Biologics
Figure Next-Generation Biologics Industrial Chain Analysis
Table Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
Table Major Buyers of Next-Generation Biologics
Table Distributors/Traders List
Figure United States Next-Generation Biologics Production and Growth Rate Forecast (2016-2021)
Figure United States Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Table United States Next-Generation Biologics Production Forecast by Type (2016-2021)
Table United States Next-Generation Biologics Consumption Forecast by Application (2016-2021)

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.